Identification of tumour-associated t-cell epitopes for vaccine development
- 1 July 2002
- journal article
- review article
- Published by Springer Nature in Nature Reviews Cancer
- Vol. 2 (7) , 514
- https://doi.org/10.1038/nrc841
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- CD4+T Cells Induced by a DNA Vaccine: Immunological Consequences of Epitope-Specific Lysosomal TargetingJournal of Virology, 2001
- Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunityEuropean Journal of Immunology, 2001
- HLA class I expression on human cancer cells: Implications for effective immunotherapyHuman Immunology, 2000
- A tyrosinase nonapeptide presented by HLA‐B44 is recognized on a human melanoma by autologous cytolytic T lymphocytesEuropean Journal of Immunology, 1996
- A lysosomal targeting signal in the cytoplasmic tail of the beta chain directs HLA-DM to MHC class II compartments.The Journal of cell biology, 1995
- Expression of the mage gene family in primary and metastatic human breast cancer: Implications for tumor antigen‐specific immunotherapyInternational Journal of Cancer, 1995
- Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell LinesScience, 1994
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- Exact prediction of a natural T cell epitopeEuropean Journal of Immunology, 1991
- Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC moleculesNature, 1991